
A rare-disease drug reported zero new bone lesions through 84 weeks.
In the OPTIMA extension, adults who stayed on Pasatru had no new lesions detected between weeks 56 and 84; the placebo group had nine.
Every serving. No expiration date. Page 2 of 3.

In the OPTIMA extension, adults who stayed on Pasatru had no new lesions detected between weeks 56 and 84; the placebo group had nine.

More than 7.86 million people have been screened. Diagnosis reached 92.4%, treatment 92.7%, and treatment in key high-risk groups 95%.

The lower dose met the trial’s main goal over 52 weeks. The higher dose did not, and the detailed results are not yet published.

A preclinical formulation held onto its biological activity for more than two months at 37°C—and matched fresh material in mouse immune-response tests.

WHO/Europe calls the result an early signal: the evaluation covers five months and independent peer review is pending.

In a 10-person safety trial, an experimental optogenetic treatment produced clinically meaningful light-sensitivity gains in six participants. It did not restore normal sight.

Human lung organoids retained resident T cells, recognized SARS-CoV-2 and responded more strongly after a simulated booster.

Functional testing on skin cells helped close difficult mitochondrial-disease diagnoses across samples from more than 30 medical centres.

The pollinators carried a precise biological treatment to as many as 88% of flowers.

The fabric let light, rain and air through — while keeping insect mouths out.

Two fins. One layer of living muscle. A light to follow.

Three remote counseling sessions and a phone tool helped young people make safer decisions in a rigorous trial.

Four weeks of at-home magnetic-field sessions produced encouraging early signals for long-COVID cognitive impairment.

A brown bear called Backpack packed on enough Alaska to win the internet’s favorite wildlife election.

A small trial suggests the first medication for lymphedema may be getting closer.

A Phase 3 trial turned the walls of a surgical cavity into the radiation treatment.

Two mice, one mountain valley, and twenty-two years of patient taxonomy.

A small scheduling change produced a surprisingly large clinical difference.

A painless test using urine and a vaginal swab showed it could accurately rule out womb cancer for most women with postmenopausal bleeding.

A Cambridge-led study gave nicotinamide riboside to eight people with mitochondrial DNA disease. It was well tolerated and showed early signs of working.

UBC divers found the first new sea spider species described in the Salish Sea in almost a century. One has red eyes and fuzzy-looking legs.

In a mouse model of multiple sclerosis, the experimental drug K-9 restored function after paralysis and vision loss had already set in. It has not been tested in people with MS.

In the TESEO trial, 450 adults received different benznidazole regimens. The 30-day, once-daily option matched the standard 60-day course in the trial and caused fewer side effects.

DirectHop uses a tiny motor and three folding legs to make controlled, repeated jumps. The prototype can clear a standard stair and twitch itself upright after a fall.